| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | +13.9% | -38.5% |
| R&D Expense | $331K | +6.2% | +20.4% |
| SG&A Expense | $2.2M | -0.2% | -6.6% |
| Operating Income | -$2.3M | +8.9% | -16.2% |
| Pre-tax Income | -$5.0M | -25.2% | -152.6% |
| Income Tax | $3K | -89.0% | +24.3% |
| Net Income | -$5.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.7M | +855.3% | +913.7% |
| Accounts Receivable | $449K | +6.4% | -66.2% |
| Inventory | $35K | -19.9% | +38.9% |
| Current Assets | $8.6M | +416.1% | +237.9% |
| Total Assets | $11.5M | +143.0% | +76.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.8M | — | — |
| Capital Expenditures | $61K | — | — |
| Investing Cash Flow | -$61K | — | — |
| Financing Cash Flow | $13.4M | — | — |
| Free Cash Flow | -$6.8M | — | — |
| -24.4% |
| -152.4% |
| EPS (Basic) | -$4.74 | -2688.2% | -2862.5% |
| EPS (Diluted) | -$4.74 | -2688.2% | -2862.5% |
| $2.4M |
| -8.8% |
| -5.3% |
| Total Liabilities | $2.6M | -61.6% | -22.9% |
| Stockholders' Equity | $8.9M | +516.7% | +185.2% |